금호석유화학Kumho PetrochemicalKumho Petrochemical — 매출 10%를 넘는 고객이 없다 — 타이어·장갑·가전으로 흩어진 고객, 이익은 부타디엔 스프레드를 따라간다No customer exceeds 10% of revenue — customers spread across tyres, gloves and home appliances; profit follows the butadiene spread売上の10%を超える顧客はいない — タイヤ・手袋・家電に分散した顧客、利益はブタジエンスプレッドに従う
DART 정기보고서(사업·반기·분기) 원문을 2014년부터 다시 받아 최종 고객이 누구인지(회사가 적은 고객사 이름·매출 10% 이상 고객·수요처), 원료를 어디서 얼마에 사는지, 그리고 그 제품과 원료가 관세청 수출입 통계(금액·물량·단가·상대국)에서 어떻게 움직이는지를 한 장에 놓았다. 마지막에 관세청 단가로 이익률 함수를 세우고 유가 → 나프타 → 제품·원료 단가로 다음 분기들을 잇는 우리 Fcst 를 붙였다. 방향을 단정하지 않고, 회사가 사고파는 값이 이익률에 어떻게 옮겨 가는지만 관측한다.The full text of DART periodic reports (annual, half-year, quarterly) is downloaded again from 2014 to put on one page who the end customers are (customer names the company gives, customers above 10% of revenue, demand sectors), where and at what price raw materials are bought, and how those products and raw materials move in Korea Customs trade statistics (value, volume, unit price, partner country). At the end, a margin function built on customs unit prices is joined by our Fcst, which links the coming quarters through oil → naphtha → product and raw-material unit prices. No direction is asserted; the page only observes how the prices at which the company buys and sells pass through to its margin.DART定期報告書(事業・半期・四半期)の原文を2014年から取り直し、最終顧客が誰か(会社が記した顧客名・売上10%以上の顧客・需要先)、原料をどこからいくらで買っているか、そしてその製品と原料が関税庁の輸出入統計(金額・数量・単価・相手国)でどう動いているかを一枚にまとめた。最後に関税庁の単価で利益率関数を立て、原油 → ナフサ → 製品・原料単価で次の四半期をつなぐ当サイトFcstを付けた。方向は断定せず、会社が売買する価格が利益率にどう波及するかだけを観測する。
먼저 보는 세 줄Three lines firstまず見る三行
Created 2026-11-13- 매출 10%를 넘는 고객이 없다 — 타이어·장갑·가전으로 흩어진 고객, 이익은 부타디엔 스프레드를 따라간다.No customer exceeds 10% of revenue — customers spread across tyres, gloves and home appliances; profit follows the butadiene spread.売上の10%を超える顧客はいない — タイヤ・手袋・家電に分散した顧客、利益はブタジエンスプレッドに従う。
- 영업이익률 TTM 6.7% (~2026Q2) · 매출 FY2025 6.92조 · P/B 0.39배 · 우리 Fcst 다음 4분기 P/E 4.1배.Operating margin TTM 6.7% (to 2026Q2) · revenue FY2025 KRW 6.92trn · P/B 0.39x · our Fcst next-four-quarter P/E 4.1x.営業利益率TTM 6.7%(〜2026Q2) · 売上高 FY2025 6.92兆ウォン · PBR 0.39倍 · 当サイトFcstの次の4四半期PER 4.1倍。
- 우리 Fcst: 2026Q3 영업이익률 10.5% (관세청 실측 3/3달) — 전진 검증 평균 오차 3.76%p vs 직전 분기 유지 4.11%p.Our Fcst: 2026Q3 operating margin 10.5% (customs data for 3 of 3 months) — mean forward-test error 3.76pp vs 4.11pp for the previous quarter carried forward.当サイトFcst: 2026Q3の営業利益率10.5%(関税庁の実測3/3か月)— フォワードテストの平均誤差3.76%pt(前四半期据え置きは4.11%pt)。
① 최종 고객 구조 — 원료 → 제품 → 직접 고객 → 최종 수요End-customer structure — raw materials → products → direct customers → final demand最終顧客の構造 — 原料 → 製品 → 直接の顧客 → 最終需要
회사가 적은 이름·문구 그대로names and wording as the company wrote them会社が記した名前・文言のまま · Data as of 2025-12 · Created 2026-11-13매출 10%를 넘는 고객이 없다(2025 사업보고서). 회사가 적은 부문별 고객 — 고무사업 부문: 한국타이어, 넥센타이어, 금호타이어, HARTALEGA, TOP GLOVE 등 · 수지사업 부문: 삼성전자, LG전자, 에치와이 등 · 에너지사업 부문: 한국전력거래소, 금호피앤비화학, 금호폴리켐 등 · 기타부문: BRIDGESTONE, TIARCO, 그린피아, 대우건설 등. 원료(본사 매입액 비중): SM 29%(에스케이피아이씨글로벌 외) · BD 57%(여천NCC 외).No customer exceeds 10% of revenue (2025 annual report). Customers by segment as the company wrote them — 고무사업 부문: 한국타이어, 넥센타이어, 금호타이어, HARTALEGA, TOP GLOVE 등 · 수지사업 부문: 삼성전자, LG전자, 에치와이 등 · 에너지사업 부문: 한국전력거래소, 금호피앤비화학, 금호폴리켐 등 · 기타부문: BRIDGESTONE, TIARCO, 그린피아, 대우건설 등. Raw materials (share of parent purchases): SM 29%(에스케이피아이씨글로벌 외) · BD 57%(여천NCC 외).売上の10%を超える顧客はいない(2025年の事業報告書)。会社が記した部門別の顧客 — 고무사업 부문: 한국타이어, 넥센타이어, 금호타이어, HARTALEGA, TOP GLOVE 등 · 수지사업 부문: 삼성전자, LG전자, 에치와이 등 · 에너지사업 부문: 한국전력거래소, 금호피앤비화학, 금호폴리켐 등 · 기타부문: BRIDGESTONE, TIARCO, 그린피아, 대우건설 등。原料(本社の仕入額比率): SM 29%(에스케이피아이씨글로벌 외) · BD 57%(여천NCC 외)。
| 연도Year年 | 부문Segment部門 | 회사가 적은 주요 고객Main customers named by the company会社が記した主要顧客 |
|---|---|---|
| 2014 | 울산사업부문 | 금호타이어,한국타이어,한국야쿠르트,대우일렉트로닉스 등 |
| 2014 | 여수사업부문 | 금호타이어,한국타이어,금호피앤비화학 등 |
| 2014 | 기타 | LG디스플레이,하이닉스반도체,비오이하이디스 등 |
| 2018 | 울산사업부문 | 금호타이어,한국타이어,한국야쿠르트,대우일렉트로닉스 등 |
| 2018 | 여수사업부문 | 금호타이어,한국타이어,금호피앤비화학 등 |
| 2018 | 기타 | LG디스플레이,하이닉스반도체,비오이하이디스 등 |
| 2022 | 고무사업부문 | 한국타이어, 넥센타이어, HARTLAEGA, TOP GLOVE 등 |
| 2022 | 수지사업부문 | 삼성전자, LG전자, 현대기아차, 한국야쿠르트 등 |
| 2022 | 에너지사업부문 | 한국전력거래소, 금호피앤비화학, 금호폴리켐 등 |
| 2022 | 기타 | BRIDGESTONE, TIARCO, 한국엔지니어링플라스틱, 포스코건설 등 |
| 2025 | 고무사업 부문 | 한국타이어, 넥센타이어, 금호타이어, HARTLAEGA, TOP GLOVE 등 |
| 2025 | 수지사업 부문 | 삼성전자, LG전자, 에치와이 등 |
| 2025 | 에너지사업 부문 | 한국전력거래소, 금호피앤비화학, 금호폴리켐 등 |
| 2025 | 기타부문 | BRIDGESTONE, TIARCO, 그린피아, 대우건설 등 |
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage
② 매출 10% 이상 고객 — 얼마나 몰려 있나Customers above 10% of revenue — how concentrated?売上10%以上の顧客 — どれだけ集中しているか
% of revenue · Data as of 2025-12 · Created 2026-11-13주석의 '주요 고객' 공시(단일 외부고객 매출이 연결·별도 매출의 10% 이상이면 금액을 적는다). '없음'은 회사가 그렇게 적은 해다. 공시가 있는 해(2018~2025)는 모두 '없음'이다.From the notes’ 'major customers' disclosure (the amount is given when revenue from a single external customer is 10% or more of consolidated or separate revenue). 'None' marks a year in which the company wrote exactly that. Every year with a disclosure (2018–2025) says 'none'.注記の「主要顧客」開示(単一の外部顧客への売上が連結・個別売上の10%以上なら金額を記す)。「なし」は会社がそう記した年だ。開示のある年(2018〜2025)はすべて「なし」だ。
| 연도Year年 | 회사 표기Company’s label会社の表記 | 매출(억원)Revenue (KRW 100mn)売上高(億ウォン) | 매출 대비Share of revenue売上比 | 회사 설명Company’s note会社の説明 |
|---|---|---|---|---|
| 2025 | 10% 이상 고객 없음(회사 기재)No customer above 10% (as stated by the company)10%以上の顧客なし(会社記載) | |||
| 2024 | 10% 이상 고객 없음(회사 기재)No customer above 10% (as stated by the company)10%以上の顧客なし(会社記載) | |||
| 2023 | 10% 이상 고객 없음(회사 기재)No customer above 10% (as stated by the company)10%以上の顧客なし(会社記載) | |||
| 2022 | 10% 이상 고객 없음(회사 기재)No customer above 10% (as stated by the company)10%以上の顧客なし(会社記載) | |||
| 2021 | 10% 이상 고객 없음(회사 기재)No customer above 10% (as stated by the company)10%以上の顧客なし(会社記載) | |||
| 2020 | 10% 이상 고객 없음(회사 기재)No customer above 10% (as stated by the company)10%以上の顧客なし(会社記載) | |||
| 2019 | 10% 이상 고객 없음(회사 기재)No customer above 10% (as stated by the company)10%以上の顧客なし(会社記載) | |||
| 2018 | 10% 이상 고객 없음(회사 기재)No customer above 10% (as stated by the company)10%以上の顧客なし(会社記載) | |||
| 2017 | 공시를 찾지 못함Disclosure not found開示が見つからない | |||
| 2016 | 공시를 찾지 못함Disclosure not found開示が見つからない | |||
| 2015 | 공시를 찾지 못함Disclosure not found開示が見つからない | |||
| 2014 | 공시를 찾지 못함Disclosure not found開示が見つからない | |||
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage
③ 부문 매출·이익 — 어느 덩어리가 버나Segment revenue and profit — which block earns?部門別の売上・利益 — どの塊が稼ぐか
KRW bn · Data as of 2025-12 · Created 2026-11-13주석의 영업부문 표(당기). 부문 이름은 그해 회사 표기를 같은 묶음으로 이었다 — 회사가 조직을 바꾼 해(예: 첨단소재 신설, 전지 물적분할)는 이름이 바뀐다.Operating-segment table in the notes (current period). Segment names follow the company’s label for each year, linked into the same groups — in years when the company reorganised (e.g. Advanced Materials created, the battery business spun off), the names change.注記の事業セグメント表(当期)。部門名はその年の会社の表記を同じまとまりとしてつないだ — 会社が組織を変えた年(例: 先端素材の新設、電池の物的分割)は名前が変わる。
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage
④ 수출·내수 — 제품별로 얼마나 밖에 파나Exports vs domestic — how much each product sells abroad輸出・内需 — 製品ごとにどれだけ海外で売るか
% export · Data as of 2025-12 · Created 2026-11-13사업의 내용 '매출실적' 표의 수출·내수(당기). 금호석유화학 표는 본사(별도) 몫만 — 금호피앤비화학 등 자회사는 따로 적어 이 줄에 없다. 로컬 L/C 수출(국내 수출업체를 거친 것)을 수출로 넣는 회사가 있다 — 회사 표기 그대로다.Exports and domestic sales from the 'sales performance' table in the business section (current period). Kumho Petrochemical’s table covers the parent (separate) only — subsidiaries such as Geumhopiaenbihwahak* are reported separately and are not in this line. Some companies count local L/C exports (sales routed through domestic exporters) as exports — shown as the company reports it.事業の内容「売上実績」表の輸出・内需(当期)。Kumho Petrochemicalの表は本社(個別)分のみ — Geumhopiaenbihwahak*などの子会社は別に記載され、この行にない。ローカルL/C輸出(国内の輸出業者を経たもの)を輸出に含める会社がある — 会社の表記のままだ。
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage
⑤ 지역별 매출 — 고객이 어디 있나Revenue by region — where the customers are地域別売上 — 顧客はどこにいるか
% of revenue · Data as of 2025-12 · Created 2026-11-13주석의 지역별 매출(당기). 지역 묶음은 회사가 해마다 다르게 적는다(예: 아시아 ↔ 아시아/오세아니아) — 같은 이름만 이었다.Revenue by region from the notes (current period). The company groups regions differently from year to year (e.g. Asia ↔ Asia/Oceania) — only identical names are linked.注記の地域別売上(当期)。地域のまとめ方は会社が年ごとに変える(例: アジア ↔ アジア/オセアニア)— 同じ名前だけをつないだ。
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage
⑥ 원재료 — 회사 매입가 vs 관세청 수입 단가Raw materials — company purchase price vs customs import unit price原材料 — 会社の仕入価格 vs 関税庁の輸入単価
ratio (company ÷ customs) · USD/t · Data as of 2026-09 · Created 2026-11-13사업보고서 '주요 원재료 가격변동추이'의 매입 단가를 관세청 수입 단가(전 국가 합, 금액 ÷ 중량)와 같은 해·같은 단위(달러/톤)로 놓았다. 1에 가까우면 회사가 시장 수입가에 산다는 뜻이다. 최근 해: 스티렌모노머(SM) 0.94배 · 부타디엔(BD) 0.94배 · 벤젠 0.99배 · 프로필렌 0.99배.The purchase prices in the annual report’s 'price trends of major raw materials' are set against customs import unit prices (all countries, value ÷ weight) for the same year and in the same unit (USD per tonne). A ratio near 1 means the company buys at the market import price. Latest year: Styrene monomer 0.94x · Butadiene 0.94x · Benzene 0.99x · Propylene 0.99x.事業報告書「主要原材料の価格変動推移」の仕入単価を、関税庁の輸入単価(全ての国の合計、金額 ÷ 重量)と同じ年・同じ単位(ドル/トン)で並べた。1に近ければ会社が市場の輸入価格で買っているという意味だ。直近の年: スチレンモノマー 0.94倍 · ブタジエン 0.94倍 · ベンゼン 0.99倍 · プロピレン 0.99倍。
| 회사 원재료 표Company raw-material table会社の原材料表 | 관세청 품목Customs item関税庁の品目 | 최근 해Latest year直近の年 | 회사 $/tCompany $/t会社 $/t | 관세청 수입 $/tCustoms import $/t関税庁の輸入 $/t | 배율Ratio倍率 | 비고Note備考 |
|---|---|---|---|---|---|---|
| SMSMSM | 스티렌모노머(SM)Styrene monomerスチレンモノマー | 2025 | 912 | 973 | 0.94 | |
| BDBDBD | 부타디엔(BD)Butadieneブタジエン | 2025 | 1,124 | 1,201 | 0.94 | |
| BENZENEBENZENEBENZENE | 벤젠Benzeneベンゼン | 2025 | 774 | 782 | 0.99 | |
| PROPYLENEPROPYLENEPROPYLENE | 프로필렌Propyleneプロピレン | 2025 | 773 | 781 | 0.99 |
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage
⑦ 제품 — 회사 판가·생산량 vs 관세청 수출Products — company selling price and output vs customs exports製品 — 会社の販売価格・生産量 vs 関税庁の輸出
ratio · t · Data as of 2026-09 · Created 2026-11-13최근 해: SBR(스티렌-부타디엔 고무) + BR(부타디엔 고무) + NB 라텍스 + NBR(고형) 0.99배 · ABS + 폴리스티렌(EPS·GPPS) 0.90배 · 페놀 + 아세톤 + 비스페놀A(BPA) 1.42배 · EPDM 1.09배. Latest year: SBR + BR + NBR latex + NBR (solid) 0.99x · ABS + Polystyrene 0.90x · Phenol + Acetone + Bisphenol A 1.42x · EPDM 1.09x. 直近の年: SBR + BR + NBRラテックス + NBR(固形) 0.99倍 · ABS + ポリスチレン 0.90倍 · フェノール + アセトン + ビスフェノールA 1.42倍 · EPDM 1.09倍。
| 회사 표Company table会社の表 | 관세청 품목Customs item関税庁の品目 | 최근 해Latest year直近の年 | 회사Company会社 | 관세청Customs関税庁 | 배율Ratio倍率 | 비고Note備考 |
|---|---|---|---|---|---|---|
| 합성고무Synthetic rubber合成ゴム | SBR(스티렌-부타디엔 고무) + BR(부타디엔 고무) + NB 라텍스 + NBR(고형)SBR + BR + NBR latex + NBR (solid)SBR + BR + NBRラテックス + NBR(固形) | 2025 | 1,400 $/t | 1,410 $/t | 0.99 | 회사 합성고무 평균판가 vs 한국 SBR·BR·NB라텍스·NBR 수출 단가(물량 가중)Company’s average synthetic-rubber selling price vs Korea’s SBR · BR · NBR latex · NBR export unit price (volume-weighted)会社の合成ゴム平均販売価格 vs 韓国のSBR・BR・NBラテックス・NBRの輸出単価(数量加重) |
| 합성수지Synthetic resins合成樹脂 | ABS + 폴리스티렌(EPS·GPPS)ABS + PolystyreneABS + ポリスチレン | 2025 | 1,439 $/t | 1,591 $/t | 0.90 | |
| 피앤비 Geumhopiaenbihwahak* Geumhopiaenbihwahak* 수 출Exports輸出 | 페놀 + 아세톤 + 비스페놀A(BPA)Phenol + Acetone + Bisphenol Aフェノール + アセトン + ビスフェノールA | 2025 | 1,284 $/t | 901 $/t | 1.42 | 금호피앤비화학 제품 수출 평균단가 vs 한국 페놀·아세톤·BPA 수출 단가The subsidiary’s average product export price vs Korea’s phenol · acetone · BPA export unit price子会社の製品輸出平均単価 vs 韓国のフェノール・アセトン・BPAの輸出単価 |
| 폴리켐 Geumhopollikem* Geumhopollikem* 제 품Products製品 | EPDMEPDMEPDM | 2025 | 2,650 $/t | 2,425 $/t | 1.09 | |
| EPDMEPDMEPDM | 회사 표에서 값을 못 읽음Could not read values from the company table会社の表から値を読めなかった | |||||
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage
⑧ 제품 수출입 — 한국 전체 물량·단가(월별)Product trade — Korea-wide volume and unit price (monthly)製品の輸出入 — 韓国全体の数量・単価(月次)
kt · USD/t · Data as of 2026-09 · Created 2026-11-13회사가 만드는 제품을 관세청 품목으로 짝지어 한국 전체 수출 물량과 수출 단가를 매달 이었다. 최근 12개월 합과 전년 같은 기간 대비, 주요 목적국은 표에.The company’s products are matched to customs items to link Korea’s total export volume and export unit price month by month. The latest 12-month total, the change on the same period a year earlier and the main destinations are in the table.会社が作る製品を関税庁の品目に対応させ、韓国全体の輸出数量と輸出単価を毎月つないだ。直近12か月の合計と前年同期比、主な仕向国は表に。
| 제품(관세청 품목)Product (customs item)製品(関税庁の品目) | 수출 백만$Exports $mn輸出 百万ドル | 수출 ktExports kt輸出 kt | 물량 YoYVolume YoY数量 前年比 | 수출 $/tExport $/t輸出 $/t | 단가 YoYPrice YoY単価 前年比 | 수입 ktImports kt輸入 kt | 주요 목적국(금액 비중)Main destinations (share of value)主な仕向国(金額比率) |
|---|---|---|---|---|---|---|---|
| ABSABSABS | 1,748 | 964.2 | -8.5% | 1,813 | +4.0% | 12.5 | China 14% · Mexico 10% · United States 8% · Vietnam 8% · Turkey 7% |
| SBR(스티렌-부타디엔 고무)SBRSBR | 1,232 | 592.1 | +0.2% | 2,081 | +4.3% | 33.9 | China 20% · United States 13% · India 11% · Indonesia 10% · Thailand 8% |
| 에폭시 수지Epoxy resinエポキシ樹脂 | 948 | 342.6 | +9.9% | 2,767 | +3.8% | 20.7 | United States 19% · China 16% · Netherlands 11% · Japan 5% · India 5% |
| BR(부타디엔 고무)BRBR | 661 | 300.6 | -2.3% | 2,199 | +6.5% | 28.3 | India 22% · Indonesia 20% · Vietnam 13% · China 12% · Thailand 9% |
| NB 라텍스NBR latexNBRラテックス | 646 | 717.3 | -7.3% | 901 | +16.4% | 0.1 | Malaysia 52% · China 19% · Vietnam 12% · Thailand 9% · Indonesia 5% |
| EPDMEPDMEPDM | 524 | 198.7 | +0.5% | 2,639 | +8.8% | 13.3 | China 36% · India 10% · Japan 7% · Germany 5% · Thailand 5% |
| 비스페놀A(BPA)Bisphenol AビスフェノールA | 307 | 252.4 | +1.5% | 1,215 | +3.2% | 26.7 | Japan 28% · Thailand 22% · India 13% · Czechia 10% · Germany 6% |
| 폴리스티렌(EPS·GPPS)Polystyreneポリスチレン | 286 | 238.8 | +3.1% | 1,199 | +2.5% | 50.4 | Vietnam 12% · United States 10% · China 9% · Japan 8% · Mexico 7% |
| NBR(고형)NBR (solid)NBR(固形) | 279 | 130.0 | -3.8% | 2,144 | +8.3% | 1.9 | China 20% · India 18% · United States 11% · Vietnam 6% · Italy 5% |
| 아세톤Acetoneアセトン | 124 | 169.8 | +4.0% | 728 | +16.6% | 0.0 | China 38% · India 19% · Japan 17% · Thailand 14% · Mexico 4% |
| 페놀Phenolフェノール | 105 | 106.6 | +20.7% | 988 | +12.2% | 97.8 | Thailand 35% · Japan 21% · India 15% · Malaysia 7% · Indonesia 6% |
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage
⑨ 원료 수입 — 한국 전체 물량·단가(월별)Raw-material imports — Korea-wide volume and unit price (monthly)原料の輸入 — 韓国全体の数量・単価(月次)
kt · USD/t · Data as of 2026-09 · Created 2026-11-13원재료 표의 품목을 관세청 품목으로 짝지어 한국 전체 수입 물량·단가·원산국을 이었다.Items in the raw-material table are matched to customs items to link Korea’s total import volume, unit price and countries of origin.原材料表の品目を関税庁の品目に対応させ、韓国全体の輸入数量・単価・原産国をつないだ。
| 원료(관세청 품목)Raw material (customs item)原料(関税庁の品目) | 수입 백만$Imports $mn輸入 百万ドル | 수입 ktImports kt輸入 kt | 물량 YoYVolume YoY数量 前年比 | 수입 $/tImport $/t輸入 $/t | 단가 YoYPrice YoY単価 前年比 | 주요 원산국(금액 비중 · $/t)Main origins (share of value · $/t)主な原産国(金額比率 · $/t) |
|---|---|---|---|---|---|---|
| 부타디엔(BD)Butadieneブタジエン | 668 | 452.6 | +23.6% | 1,476 | +13.1% | China 29% ($1,819) · Netherlands 18% ($1,603) · India 15% ($1,514) · Brazil 11% ($1,288) · United States 10% ($1,146) |
| 스티렌모노머(SM)Styrene monomerスチレンモノマー | 595 | 515.5 | +3.9% | 1,154 | +12.8% | China 52% ($1,207) · Japan 25% ($1,134) · Taiwan 23% ($1,070) · Netherlands 0% ($54,165) · Germany 0% ($134,964) |
| 프로필렌Propyleneプロピレン | 355 | 371.7 | +30.0% | 956 | +19.0% | Japan 62% ($837) · China 26% ($1,275) · Taiwan 7% ($1,081) · Philippines 4% ($1,309) · United States 0% ($36,455) |
| 아크릴로니트릴(AN)Acrylonitrileアクリロニトリル | 262 | 194.4 | -4.4% | 1,350 | +19.2% | China 77% ($1,362) · Taiwan 22% ($1,285) · Japan 1% ($1,836) · India 0% ($4,264) · Netherlands 0% ($51,354) |
| 벤젠Benzeneベンゼン | 234 | 250.0 | +213.5% | 934 | +7.0% | Japan 92% ($925) · Taiwan 5% ($998) · Philippines 2% ($1,167) · Indonesia 1% ($1,126) · China 0% ($266,807) |
| 에틸렌Ethyleneエチレン | 229 | 183.5 | +710.8% | 1,250 | +39.7% | China 74% ($1,409) · Japan 20% ($899) · United States 4% ($1,058) · Vietnam 1% ($1,453) · Taiwan 0% ($160,638) |
| 큐멘Cumeneクメン | 6 | 6.0 | -32.3% | 1,018 | +7.8% | Japan 100% ($1,016) · United States 0% ($480,091) · China 0% ($342,000) · Switzerland 0% · Germany 0% |
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage
⑩ 나프타 — 한국 수입 물량·단가와 브렌트Naphtha — Korea’s import volume and unit price, and Brentナフサ — 韓国の輸入数量・単価とブレント
kt · USD/t · USD/bbl · Data as of 2026-09 · Created 2026-11-13나프타는 크래커의 원료다 — 에틸렌·프로필렌·부타디엔·벤젠이 여기서 나와 이 네 회사의 원료(또는 원료의 원료)가 된다. 최근 12개월 수입 20953kt(전년 대비 -23.7%), 단가 $713/t(전년 대비 +12.3%). 주요 원산국: UAE 16% · Algeria 16% · United States 11% · Oman 9% · India 8%. 수입 단가는 브렌트 당월·전월·전전월 값으로 설명된다(월별 적합 R² 0.91) — 이 다리로 관세청이 아직 없는 달을 잇는다.Naphtha is the feedstock of crackers — ethylene, propylene, butadiene and benzene come out of it and become the raw materials (or the raw materials’ raw materials) of these four companies. Imports over the latest 12 months 20953 kt (-23.7% YoY), unit price $713/t (+12.3% YoY). Main origins: UAE 16% · Algeria 16% · United States 11% · Oman 9% · India 8%. The import unit price is explained by Brent in the same month and the two months before (monthly fit R² 0.91) — this bridge links the months for which customs data are not out yet.ナフサはクラッカーの原料だ — エチレン・プロピレン・ブタジエン・ベンゼンがここから生まれ、この4社の原料(または原料の原料)になる。直近12か月の輸入20953kt(前年比-23.7%)、単価$713/t(前年比+12.3%)。主な原産国: UAE 16% · Algeria 16% · United States 11% · Oman 9% · India 8%。輸入単価はブレントの当月・前月・前々月の値で説明される(月次の当てはまりR² 0.91)— このブリッジで関税庁のデータがまだない月をつなぐ。
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage
⑪ 우리 Fcst — 관세청 단가로 세운 이익률, 유가로 잇는 다음 분기Our Fcst — a margin built on customs unit prices, bridged to the next quarters by oil当サイトFcst — 関税庁の単価で立てた利益率、原油でつなぐ次の四半期
% · USD/t · Data as of 2026-09 · Created 2026-11-13대상: 연결 분기 영업이익률, 2016Q1~2026Q2(42분기). 스프레드 = 합성고무 바스켓(SBR·BR·NB라텍스·NBR) 수출 단가 − (BD 0.75 + SM 0.25) 수입 단가. BD:SM = SBR 표준 결합 스티렌(약 23.5%)에 맞춘 고정 배합 · 수지·페놀·EPDM 을 섞은 부문 합산 바스켓은 이익률과 상관이 사라져 뺐다. 전진 검증(그 분기 전 자료로만 맞추고 그 분기를 맞힘) 평균 오차: 고른 모델(결합(직전 분기 반 + 수준 모델 반)) 3.76%p vs 직전 분기 유지 4.11%p — 모델이 직전 분기보다 낫다. 전 기간 적합 R² 0.69. 202609 까지는 관세청 실측 단가, 그 뒤는 브렌트를 마지막 달 평균($107.2/bbl)으로 둔 다리다. 유가 경로 자체는 모델 밖이다.Target: consolidated quarterly operating margin, 2016Q1–2026Q2 (42 quarters). Spread = 합성고무 바스켓(SBR·BR·NB라텍스·NBR) 수출 단가 − (BD 0.75 + SM 0.25) 수입 단가. BD:SM = SBR 표준 결합 스티렌(약 23.5%)에 맞춘 고정 배합 · 수지·페놀·EPDM 을 섞은 부문 합산 바스켓은 이익률과 상관이 사라져 뺐다. Mean forward-test error (fitted only on data from before each quarter, then scored on it): chosen model (combination (half previous quarter + half level model)) 3.76pp vs 4.11pp for the previous quarter carried forward — the model does better than the previous quarter. Full-period fit R² 0.69. Up to 202609, measured customs unit prices; after that, a bridge holding Brent at the last month’s average ($107.2/bbl). The oil path itself is outside the model.対象: 連結の四半期営業利益率、2016Q1〜2026Q2(42四半期)。スプレッド = 합성고무 바스켓(SBR·BR·NB라텍스·NBR) 수출 단가 − (BD 0.75 + SM 0.25) 수입 단가。BD:SM = SBR 표준 결합 스티렌(약 23.5%)에 맞춘 고정 배합 · 수지·페놀·EPDM 을 섞은 부문 합산 바스켓은 이익률과 상관이 사라져 뺐다。フォワードテスト(その四半期より前のデータだけで当てはめてその四半期を当てる)の平均誤差: 選んだモデル(組み合わせ(前四半期半分 + 水準モデル半分))3.76%pt 対 前四半期据え置き 4.11%pt — モデルが前四半期より良い。全期間の当てはまりR² 0.69。202609までは関税庁の実測単価、その後はブレントを最終月の平均($107.2/bbl)に置いたブリッジだ。原油の経路そのものはモデルの外だ。
| 분기Quarter四半期 | 관세청 실측 달Customs months observed関税庁の実測月 | 영업이익률Operating margin営業利益率 | 매출(억원)Revenue (KRW 100mn)売上高(億ウォン) | 영업이익(억원)Operating profit (KRW 100mn)営業利益(億ウォン) |
|---|---|---|---|---|
| 2026Q3 Fcst | 3/3 | 10.5% | 16,380 | 1,728 |
| 2026Q4 Fcst | 0/3 | 9.8% | 16,709 | 1,642 |
| 2027Q1 Fcst | 0/3 | 8.7% | 16,406 | 1,425 |
| 2027Q2 Fcst | 0/3 | 8.3% | 16,354 | 1,350 |
| 2027Q3 Fcst | 0/3 | 8.0% | 16,354 | 1,315 |
| 2027Q4 Fcst | 0/3 | 7.9% | 16,354 | 1,298 |
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage
⑫ 분기 실적 · P/B · ROEQuarterly results · P/B · ROE四半期業績 · PBR · ROE
% · x · Data as of 2026-06-30 · Created 2026-11-13P/B = 분기말(이하 마지막 거래일) 보통주·우선주 시가총액 ÷ 분기말 지배주주 자본. ROE = 최근 4분기 지배주주 순이익 ÷ 평균 지배주주 자본. 현재 P/B 0.39배(2026-11-10 시세 ÷ 2026-06-30 자본).P/B = market capitalisation of common and preferred shares at quarter-end (the last trading day) ÷ quarter-end equity attributable to owners of the parent. ROE = net profit attributable to owners of the parent over the last four quarters ÷ average equity attributable to owners. Current P/B 0.39x (2026-11-10 price ÷ 2026-06-30 equity).PBR = 四半期末(最終取引日)の普通株・優先株の時価総額 ÷ 四半期末の親会社株主に帰属する自己資本。ROE = 直近4四半期の親会社株主に帰属する当期純利益 ÷ 平均の親会社株主資本。現在のPBR 0.39倍(2026-11-10の株価 ÷ 2026-06-30の資本)。
| 연도Year年 | 매출Revenue売上高 | 영업이익Operating profit営業利益 | 지배 순이익Net profit (owners)親会社株主純利益 | 영업현금흐름Operating cash flow営業キャッシュフロー | 설비투자Capex設備投資 | FCF | 배당 지급Dividends paid配当支払 | 자사주 취득Share buybacks自己株式取得 |
|---|---|---|---|---|---|---|---|---|
| 2025 | 69,151 | 2,718 | 2,909 | 7,153 | 1,944 | 5,209 | 575 | 500 |
| 2024 | 71,550 | 2,728 | 3,486 | 3,223 | 4,362 | -1,139 | 767 | 500 |
| 2023 | 63,225 | 3,590 | 4,468 | 6,307 | 5,898 | 409 | 1,467 | 1,000 |
| 2022 | 79,756 | 11,477 | 10,254 | 5,135 | 4,277 | 858 | 2,808 | 1,501 |
| 2021 | 84,618 | 24,068 | 19,655 | 21,270 | 3,538 | 17,733 | 1,158 | — |
| 2020 | 48,095 | 7,422 | 5,829 | 7,715 | 1,754 | 5,961 | 409 | 0 |
| 2019 | 49,779 | 3,678 | 2,946 | 5,577 | 1,727 | 3,850 | 367 | 0 |
| 2018 | 55,849 | 5,546 | 4,912 | 4,846 | 1,341 | 3,505 | 273 | 299 |
| 2017 | 50,648 | 2,626 | 2,136 | 4,210 | 1,060 | 3,151 | 221 | — |
| 2016 | 39,704 | 1,571 | 732 | 2,968 | 2,727 | 240 | 225 | 3,108 |
| 2015 | 39,345 | 1,640 | 1,189 | 4,832 | 3,898 | 934 | 420 | 4,286 |
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage
⑬ 네 회사 나란히 — 복합 vs 단순The four companies side by side — complex vs simple4社を並べて — 複合 vs 単純
Data as of 2025-12 · Created 2026-11-13같은 기준으로 고객·제품·원료가 얼마나 흩어져 있는지 셌다. 부문 집중도는 부문 매출 비중 제곱의 합(1 = 한 부문). 마지막 열 둘은 우리 Fcst 의 전진 오차 — 구조가 단순하다고 이익률이 원료 스프레드를 더 잘 따라가는 것은 아니다(각 회사 페이지의 Fcst 절).On the same basis, a count of how widely customers, products and raw materials are spread. Segment concentration is the sum of squared segment revenue shares (1 = a single segment). The last two columns are our Fcst’s forward errors — a simpler structure does not mean the margin tracks the raw-material spread better (see the Fcst section on each company page).同じ基準で、顧客・製品・原料がどれだけ分散しているかを数えた。部門集中度は部門売上比率の二乗和(1 = 単一部門)。最後の2列は当サイトFcstのフォワード誤差 — 構造が単純だからといって利益率が原料スプレッドによりよく追随するわけではない(各社ページのFcstの節)。
| 회사Company会社 | 부문 수Segments部門数 | 부문 집중도Segment concentration部門集中度 | 10% 고객 합10% customers, total10%顧客の合計 | 수출 비중Export share輸出比率 | 최대 원재료 비중Largest raw-material share最大原材料比率 | 짝지은 제품·원료Matched products · inputs対応させた製品・原料 | Fcst 오차 vs 직전 분기Fcst error vs previous quarterFcst誤差 vs 前四半期 | P/BP/BPBR | Fwd P/EFwd P/E予想PER |
|---|---|---|---|---|---|---|---|---|---|
| LG화학LG ChemLG Chem | 5 | 0.42 | 11% | 47% | 48% | 18 · 11 | 2.2 vs 3.5%ppp%pt | 0.50 | — |
| 코스모신소재Cosmo Advanced Materials & TechnologyCosmo Advanced Materials & Technology | 1 | 1.00 | 85% | 42% | 73% | 4 · 5 | 1.1 vs 1.2%ppp%pt | 2.07 | 77.9 |
| 금호석유화학Kumho PetrochemicalKumho Petrochemical | 3 | 0.47 | 없음noneなし | 69% | 57% | 11 · 7 | 3.8 vs 4.1%ppp%pt | 0.39 | 4.1 |
| KPX케미칼KPX ChemicalKPX Chemical | 1 | 1.00 | 11% | 63% | 71% | 1 · 2 | 1.9 vs 1.9%ppp%pt | 0.31 | 5.0 |
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage